UH
EW icon

Unigestion Holding’s Edwards Lifesciences EW Stock Holding History

Unigestion Holding’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,164
Closed -$450K – 239
2020
Q1 		$450K Buy
+7,164
New +$517K 0.02% 211
2019
Q3 		– Sell
-8,421
Closed -$519K – 236
2019
Q2 		$519K Buy
+8,421
New +$509K 0.01% 222

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Unigestion Holding's EW Position: Q2 2020 in Review

Unigestion Holding sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 7,164 shares — an estimated $450K sold.

Unigestion Holding first reported a position in EW in Q2 2019 and held it in 2 quarters. The position peaked at $519K in Q2 2019. 1,047 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • Unigestion Holding reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
  • Unigestion Holding sold 7,164 Edwards Lifesciences shares in Q2 2020, an estimated $450K.
  • Unigestion Holding first reported a position in Edwards Lifesciences in Q2 2019 and held it in 2 quarters.
  • Unigestion Holding's Edwards Lifesciences position peaked at $519K in Q2 2019.
  • 1,047 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on Unigestion Holding's 13F filing for Q2 2020, filed 5 Aug 2020.